An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries

PURPOSE: Denosumab (administered via subcutaneous injection) demonstrated superior efficacy versus the intravenously administered zoledronic acid in the prevention of skeletal-related events in an integrated analysis of three head-to-head phase III trials in patients with bone metastases secondary t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Body, Jean-Jacques, Gatta, Francesca, De Cock, Erwin, Tao, Sunning, Kritikou, Persefoni, Wimberger, Pauline, Mebis, Jeroen, Peeters, Marc, Pedrazzoli, Paolo, Caraceni, Augusto, Adamo, Vincenzo, Hechmati, Guy
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527062/
https://ncbi.nlm.nih.gov/pubmed/28429148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3697-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados